Immunotope, Immunovaccine receive US patent for cancer vaccine antigens
Immunotope and Immunovaccine, two clinical stage biotechnology companies, have received an official Notice of Allowance from the US Patent and Trademark Office for a new US Patent specific to the...
View ArticlePfizer to support immatics’ IMA901 Phase III trial in advanced renal cell...
Immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that Pfizer has agreed to support its...
View ArticleUSPTO issues patent to Rexahn’s new anti-cancer arylisoquinolinamine compounds
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the United States Patent &...
View ArticleSantaris Pharma wins two LNA patent re-examination cases in the U.S.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination...
View Article
